IMU Biosciences Joins UK Cancer Immunotherapy Consortium
07 Oct 2024 //
GLOBENEWSWIRE
IMU Biosciences Appoints New CEO and CBO
17 Sep 2024 //
GLOBENEWSWIRE
IMU Biosciences secures £11.5 million in Series A funding
24 Jan 2024 //
GLOBENEWSWIRE